Penobscot Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.5M Buy
77,452
+1,053
+1% +$227K 1.34% 17
2026
Q1
$16.6M Sell
76,399
-677
-0.9% -$150K 1.3% 19
2025
Q4
$17.6M Buy
77,076
+345
+0.4% +$78.6K 1.33% 16
2025
Q3
$17.8M Buy
76,731
+508
+0.7% +$103K 1.37% 14
2025
Q2
$14.1M Sell
76,223
-1,557
-2% -$289K 1.21% 20
2025
Q1
$16.3M Buy
77,780
+327
+0.4% +$63.6K 1.53% 14
2024
Q4
$13.8M Buy
77,453
+491
+0.6% +$90.3K 1.25% 19
2024
Q3
$15.2M Buy
76,962
+809
+1% +$151K 1.37% 18
2024
Q2
$13.1M Buy
76,153
+1,755
+2% +$291K 1.26% 20
2024
Q1
$13.5M Sell
74,398
-320
-0.4% -$55.1K 1.43% 17
2023
Q4
$11.6M Buy
74,718
+775
+1% +$113K 1.36% 19
2023
Q3
$11M Buy
73,943
+1,431
+2% +$210K 1.5% 17
2023
Q2
$9.77M Sell
72,512
-244
-0.3% -$35.8K 1.61% 15
2023
Q1
$11.6M Buy
72,756
+346
+0.5% +$52.9K 2.02% 8
2022
Q4
$11.7M Sell
72,410
-311
-0.4% -$47.7K 2.05% 9
2022
Q3
$9.76M Sell
72,721
-20
-0% -$2.87K 1.82% 15
2022
Q2
$11.1M Buy
72,741
+351
+0.5% +$53.6K 1.92% 10
2022
Q1
$11.7M Sell
72,390
-698
-1% -$101K 1.71% 14
2021
Q4
$9.9M Sell
73,088
-3,484
-5% -$412K 1.34% 25
2021
Q3
$8.26M Buy
76,572
+205
+0.3% +$23.4K 1.23% 26
2021
Q2
$8.6M Sell
76,367
-420
-0.5% -$47.3K 1.28% 26
2021
Q1
$8.31M Sell
76,787
-930
-1% -$99.5K 1.32% 27
2020
Q4
$8.33M Sell
77,717
-145
-0.2% -$13.9K 1.4% 22
2020
Q3
$6.82M Sell
77,862
-112
-0.1% -$10.5K 1.29% 26
2020
Q2
$7.66M Sell
77,974
-1,120
-1% -$98.6K 1.57% 20
2020
Q1
$6.03M Sell
79,094
-3,370
-4% -$287K 1.42% 21
2019
Q4
$7.3M Sell
82,464
-5,800
-7% -$482K 1.37% 21
2019
Q3
$6.68M Sell
88,264
-5,356
-6% -$367K 1.33% 22
2019
Q2
$6.81M Sell
93,620
-380
-0.4% -$29.9K 1.39% 19
2019
Q1
$7.58M Sell
94,000
-6,079
-6% -$497K 1.6% 14
2018
Q4
$9.23M Sell
100,079
-4,290
-4% -$377K 2.22% 5
2018
Q3
$9.87M Hold
104,369
2.13% 5
2018
Q2
$9.67M Buy
104,369
+1,900
+2% +$186K 2.25% 5
2018
Q1
$9.7M Buy
102,469
+7,665
+8% +$842K 2.33% 3
2017
Q4
$9.17M Buy
94,804
+619
+0.7% +$58.3K 2.54% 3
2017
Q3
$8.37M Buy
94,185
+1,145
+1% +$87.2K 2.51% 4
2017
Q2
$6.75M Buy
93,040
+3,520
+4% +$237K 2.17% 6
2017
Q1
$5.83M Buy
89,520
+1,440
+2% +$90.5K 1.95% 8
2016
Q4
$5.51M Sell
88,080
-675
-0.8% -$41.2K 1.91% 9
2016
Q3
$5.6M Buy
88,755
+4,792
+6% +$310K 1.97% 8
2016
Q2
$5.2M Buy
83,963
+3,854
+5% +$235K 1.86% 10
2016
Q1
$4.58M Sell
80,109
-14,780
-16% -$824K 1.71% 12
2015
Q4
$5.62M Sell
94,889
-715
-0.7% -$41.2K 1.76% 12
2015
Q3
$5.2M Buy
95,604
+1,230
+1% +$80.1K 1.74% 12
2015
Q2
$6.34M Buy
94,374
+2,950
+3% +$193K 1.97% 10
2015
Q1
$5.35M Buy
91,424
+3,230
+4% +$195K 1.69% 13
2014
Q4
$5.77M Buy
88,194
+1,095
+1% +$69K 1.82% 10
2014
Q3
$5.03M Buy
87,099
+1,270
+1% +$70.5K 1.67% 13
2014
Q2
$4.84M Sell
85,829
-50
-0.1% -$2.62K 1.63% 12
2014
Q1
$4.41M Buy
85,879
+588
+0.7% +$29.7K 1.56% 13
2013
Q4
$4.5M Buy
85,291
+1,680
+2% +$82.6K 1.6% 13
2013
Q3
$3.74M Buy
83,611
+2,680
+3% +$119K 1.47% 15
2013
Q2
$3.35M Buy
+80,931
New +$3.54M 1.39% 17

Other funds holding ABBV

Penobscot Investment Management's ABBV Position: Q2 2026 in Review

Penobscot Investment Management increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $227K and bringing the position to 77,452 shares worth $19.5M. The position accounts for 1.34% of the portfolio, ranked #17.

Penobscot Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Penobscot Investment Management held 77,452 shares of AbbVie worth $19.5M as of Q2 2026.
  • Penobscot Investment Management bought 1,053 AbbVie shares in Q2 2026, an estimated $227K.
  • AbbVie made up 1.34% of Penobscot Investment Management's portfolio in Q2 2026, its #17 holding.
  • Penobscot Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.